Latest Breaking News On - Regulatory affairs for amylyx pharmaceuticals - Page 1 : comparemela.com

An FDA advisory panel reversed its March decision to reject a novel drug for ALS, citing persuasive new evidence and clinician support.

United statesTammy sarnelliJustin kleeTeresa buracchioEmily freilichCaleb alexanderBilly dunnRegulatory affairs for amylyx pharmaceuticalsAmylyx pharmaceuticals incIndiana university school of medicineCentral nervous system drugs advisory committeeDrug associationOffice of neuroscienceAmylyx pharmaceuticalsDivision of neurologyMedscape medical news